Novel Therapy of PAD by Combined Transplantation of BMCs
We analyze the effects of combined intramuscular and intraarterial transplantation of BMCs in patients with PAD. BMCs were transplanted into the ischemic limb.
After 2 and 13 months walking distance and perfusion indices were monitored.
Peripheral Arterial Disease
Procedure: intraarterial and intramuscular injection of BMCs
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Transplantation of Autologous Mononuclear Bone Marrow Stem Cells in Patients With Peripheral Arterial Disease (TAM-PAD Study)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00411840
|Contact: Thomas Bartsch, MDemail@example.com|
|Duesseldorf, Germany, 40225|
|Contact: Bodo E Strauer, MD +492118118801 firstname.lastname@example.org|
|Principal Investigator: Thomas Bartsch, MD|
|Study Director:||Bodo E Strauer, MD||Heinrich-Heine University, Duesseldorf|